Market Place
Sourcing Support
TFF Pharma Reports Positive Outcomes From Tacrolimus Powder Trial
06 Aug 2024 //
GLOBENEWSWIRE
TFF provides regulatory update on Tacrolimus Inhalation Powder (TFF TAC)
24 Jun 2024 //
GLOBENEWSWIRE
TFF Provides Update On TAC Inhalation Powder Lung Transplant Rejection Trial
15 May 2024 //
GLOBENEWSWIRE
TFF Pharma Ph2 TFF TAC Data for Lung Transplant at ISHLT
29 Apr 2024 //
GLOBENEWSWIRE
Biocon receives approval from SAHPRA for Tacrolimus Capsule
22 Apr 2024 //
INDINPHARMAPOST
TFF: More Positive Tacrolimus Inhalation Phase 2 Data
15 Apr 2024 //
GLOBENEWSWIRE
TFF Pharmaceuticals Announces Updated Data from the TFF TAC & TFF VORI Programs
27 Mar 2024 //
GLOBENEWSWIRE
TFF Announces Oral Presentation Phase 2 Study of Tacrolimus Inhalation Powder
25 Mar 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of March 1, 2023
01 Mar 2023 //
FDA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
REGiMMUNE touts `compelling` data in stem call transplants
20 Dec 2022 //
FIERCEBIOTECH
Enforcement Report - Week of August 10, 2022
10 Aug 2022 //
FDA
Enforcement Report - Week of June 15, 2022
14 Jun 2022 //
FDA
FDA Confirms Paragraph IV Patent Litigation for Tacrolimus
21 May 2022 //
FDA
The Product Monograph for Protopic has been updated
04 Oct 2021 //
BIOSPACE
The Product Monograph for Protopic has been updated
04 Oct 2021 //
BIOSPACE
Alkem Labs`s Generic Tacrolimus Receives Approval In US
17 Nov 2020 //
FDA
Glenmark Pharm`s Generic Tacrolimus Receives Approval In US
12 Nov 2020 //
FDA
Biocon Pharma Generic Tacrolimus Receives Approval in US
12 Nov 2020 //
FDA
Concord Biotech Generic Tacrolimus Receives Approval in US
12 Nov 2020 //
FDA
Deciphera Presents Data from QINLOCK® (Ripretinib) Program at (CTOS)
11 Nov 2020 //
BUSINESSINSIDER
TFF Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder
20 Oct 2020 //
BIOSPACE
TFF Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder
20 Oct 2020 //
BUSINESSWIRE
Sandoz launches once-daily generic tacrolimus for transplant patients in Europe
04 Jun 2020 //
PRESS RELEASE
Accord Healthcare`s Generic Tacrolimus Receives Approval in US
31 Jan 2019 //
FDA
Prescription Alternatives Inc Receives FDA Form 483
20 Dec 2018 //
FDA
Astellas, Sunovion and Shield breach ABPI Code
18 Dec 2018 //
PHARMA TIMES
Auritec Pharms Completes Enrollment for its SR Depot Tacrolimus Clinical Trial
16 Nov 2018 //
PR NEWSWIRE
FDA Accepts Veloxis’s sNDA for the De Novo Indication for ENVARSUS XR®
20 Apr 2018 //
GLOBENEWSWIRE
Glenmark Pharm’s Generic Tacrolimus Receives Approval In US
18 Apr 2018 //
FDA
Veloxis Announces the Publication of ASERTAA Ph IIIb study of ENVARSUS XR®
28 Mar 2018 //
PR NEWSWIRE
Teva B.V. Tacforius (tacrolimus) Receives Approval In Europe
26 Jan 2018 //
EMA
Belcher Pharm’s Generic Tacrolimus Receives Approval In US
05 Dec 2017 //
FDA
CHMP recommends Teva`s generic version of Astellas` Advagraf
16 Oct 2017 //
PMLIVE
Hospira’s Generic Tacrolimus Receives Approval In US
28 Aug 2017 //
FDA
Veloxis signs agreement with Italy’s Chiesi
08 Jun 2017 //
BIOSPECTRUM
Veloxis & Endo Ventures Jointly Announce Agreement for Paladin Labs Envarsus XR
06 Jun 2017 //
PR NEWSWIRE
Veloxis Announces Agreement with Chiesi Farmaceutici S.p.A.
06 Jun 2017 //
GLOBENEWSWIRE
Enforcement Report - Week of March 22, 2017
22 Mar 2017 //
FDA
Loading of tacrolimus containing lipid based drug delivery systems
09 Aug 2016 //
PHARMA-EXCIPIENTS
Using Supercritical Fluid Technology in Preparation of Tacrolimus Dispersions
02 May 2016 //
PHARMA-EXCIPIENTS
Veloxis Launches Envarsus®XR for Treatment of Kidney Transplant Patients in US
07 Dec 2015 //
PR NEWS WIRE
Biologictx® Is A Proud Pharmacy Provider For Envarsus® XR
01 Dec 2015 //
PR NEWS WIRE
LEO Pharma Puts Up €675 Million for Astellas`s Global Dermatology Biz
11 Nov 2015 //
BIOSPACE
Veloxis Announce Phase III-b STRATO Study of Envarsus® XR
21 Sep 2015 //
PR NEWS WIRE
US FDA grants Orphan drug status to Veloxis` Envarsus for prophylaxis of organ rejection
17 Aug 2015 //
PHARMABIZ
Envarsus XR receives FDA approval for treatment of kidney transplant recipients
11 Jul 2015 //
NEWS MEDICAL
Astellas Dodges Trial Over Alleged Prograf Generics Delay
22 Jan 2015 //
FIERCE PHARMA
U S District Court Sets Briefing Schedule in Veloxis Litigation
14 Jan 2015 //
VELOXIS
Veloxis Confirms Receipt of U.S. Food and Drug Administration Decision
13 Jan 2015 //
VELOXIS PHARMACEUTICALS
